Shun Tezuka
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions.
Journal: The Lancet. Oncology
Published: February 19, 2025
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.
Journal: The Lancet. Oncology
Published: February 19, 2025
Impact of Statin Use on Survival in Patients With Unresectable Pancreatic cancer Receiving Gemcitabine Plus Nab-Paclitaxel: A Multicenter Retrospective Study.
Journal: Pancreas
Published: February 10, 2025
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer.
Journal: Therapeutic advances in medical oncology
Published: February 03, 2025
Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score-matched analysis.
Journal: Journal of radiation research
Published: October 28, 2024
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case Report.
Journal: Case reports in gastroenterology
Published: February 28, 2024
Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 08, 2024
Chemotherapy for biliary tract cancer -current status and future prospects
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: April 09, 2023
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Journal: BMC cancer
Published: October 31, 2022
Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: A retrospective study.
Journal: Oncology letters
Published: April 28, 2022
Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: March 21, 2022
Last Updated: 09/26/2026